Asklep Inc. and HCR announced a non-exclusive collaboration in June 2006, to meet the growing global needs of their pharmaceutical clients, by increasing the clinical capabilities and services of each, with the expanded geographical coverage... read more

Since 2006, HCR and CTI have a non-exclusive agreement to expand the clinical trial services of each company into each others markets, to better serve clients at all stages of drug, device and market development... read more